Educational Intervention for Lung Cancer

NA
Overseen ByNicolas Anderson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Fred Hutchinson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to evaluate how effectively an educational tool, the Lung Toolkit, helps American Indian/Alaskan Native (AI/AN) cigarette smokers understand lung cancer and the importance of screening. The Lung Toolkit includes a website and a special pouch containing resources such as stories from community members, facts about lung health, and motivational messages. The study seeks AI/AN cigarette smokers with a history of smoking at least 10 packs a year who wish to improve their knowledge about lung health. As an unphased trial, it offers participants the chance to contribute to significant educational research that can enhance community health awareness.

Do I have to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational intervention rather than medication changes.

What prior data suggests that this educational intervention is safe?

Research has shown that educational programs, such as the Lung Toolkit, are safe for participants. These programs aim to increase knowledge without posing medical risks. Early results indicate that they can significantly enhance understanding of lung cancer and help reduce associated stigma. No negative effects have been reported from using these educational materials. As this trial involves learning tools rather than medication or medical procedures, it is considered safe. Participants use resources like a website and a pouch with motivational messages, which do not pose health risks.12345

Why are researchers excited about this trial?

The Lung Toolkit Educational Intervention is unique because it focuses on empowering patients with knowledge and resources rather than using pharmaceuticals or surgical procedures. Traditional lung cancer treatments like chemotherapy, radiation, and surgery target the disease directly, often with significant side effects. In contrast, the Lung Toolkit offers a novel approach by providing educational resources and guided support aimed at prevention and improving lung health. Researchers are excited about this trial because it could lead to a patient-centered approach that enhances understanding and potentially reduces the risk of lung-related issues, empowering patients to take an active role in their health management.

What evidence suggests that the Lung Toolkit educational intervention is effective for improving knowledge about lung cancer and lung cancer screening among AI/AN cigarette smokers?

Research has shown that educational programs can increase awareness of lung cancer and promote early detection. In this trial, participants will receive the Lung Toolkit, designed to enhance knowledge about lung cancer and screening, particularly for American Indian/Alaskan Native communities. One study found that similar programs significantly increased lung cancer screening rates from 15.9% to a higher percentage. Another analysis demonstrated that these programs improved screening in high-risk groups, increasing the likelihood by 1.70 times. This evidence suggests that the Lung Toolkit could effectively enhance understanding and encourage action towards lung cancer screening.34678

Who Is on the Research Team?

MT

Matthew Triplette, MD, MPH

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Are You a Good Fit for This Trial?

This trial is for American Indian and Alaskan Native adults who currently smoke cigarettes. Participants should be interested in learning more about lung cancer and screening options.

Inclusion Criteria

Self-identify as AI/AN
Self-reported 10 pack-year smoking history (commercial tobacco i.e. cigarettes)
I am between 50 and 80 years old.
See 1 more

Exclusion Criteria

I do not have cognitive problems that affect my ability to give consent.
Having less than a 10 pack-year history of smoking commercial tobacco
I am younger than 50 or older than 80 years old.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2 weeks

Intervention

Participants receive the Lung Toolkit materials and a guided review over 60 minutes, followed by 30 days of using the materials

4 weeks
1 visit (in-person) for guided review

Follow-up

Participants are monitored for acceptability, user behavior, and knowledge improvement post-intervention

2 weeks
1 visit (virtual) for post-intervention assessment

What Are the Treatments Tested in This Trial?

Interventions

  • Lung Toolkit Educational Intervention

Trial Overview

The study is testing an educational program called the Lung Toolkit, which includes a website with information and stories, plus a physical pouch with motivational messages and ceremonial herbs. The goal is to see if it improves knowledge about lung cancer and screening.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Prevention (Lung Toolkit)Experimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Fred Hutchinson Cancer Center

Lead Sponsor

Trials
583
Recruited
1,341,000+

Bristol-Myers Squibb

Industry Sponsor

Trials
2,731
Recruited
4,127,000+
Headquarters
New York City, USA
Known For
Oncology & Cardiovascular
Top Products
Eliquis, Opdivo, Revlimid, Orencia
Christopher Boerner profile image

Christopher Boerner

Bristol-Myers Squibb

Chief Executive Officer since 2023

PhD in Business Administration from the Haas School of Business, University of California, Berkeley; BA in Economics and History from Washington University in St. Louis

Deepak L. Bhatt profile image

Deepak L. Bhatt

Bristol-Myers Squibb

Chief Medical Officer since 2024

MD from Yale University; MSc in Clinical Epidemiology from the University of Pennsylvania

Citations

Promoting lung cancer awareness, help-seeking and early ...

This systematic review describes the effect of recent interventions to improve LC awareness, help-seeking and early detection.

Implementation Resources Archive

The interactive tool quantifies and enables the comparison of data on hundreds of risk factors, injuries and diseases, including lung cancer.

Lung Cancer Awareness Toolkit

Lung cancer screening has saved 80,000 additional years of life, leading to $40 million in savings, which would increase to 500,000 additional ...

Intervention Leads to Increase in Lung Cancer Screenings

Lung cancer screening rates increased due to a multifaceted intervention, the intervention improved lung cancer screening from 15.9 percent to ...

Interventions targeted to improve lung cancer screening ...

The meta-analysis findings revealed that lung cancer screening uptake was enhanced among high-risk individuals receiving various interventions (OR, 1.70; 95% CI ...

An Educational Intervention (Lung Toolkit) for Improving ...

The Lung Toolkit intervention may be effective for improving knowledge about lung cancer and lung cancer screening among AI/AN cigarette smokers ...

Using AI to Design and Develop Online Educational Modules ...

Preliminary findings showed significant improvements in knowledge, lung cancer-related stigma, and health beliefs following module completion,

Smoking cessation and lung cancer screening

The ALA and the National Cancer Institute (NCI) have created toolkits for use in community settings with the goal of improving screening ...